Flerie AB (publ) (FLERIE) Notes FDA Approval for Egetis Drug

Flerie said its portfolio company Egetis Therapeutics received FDA approval for EMCITATE (tiratricol) for MCT8 deficiency and was granted a Rare Pediatric Disease Priority Review Voucher.Material DetailsContext by AI AnalystThis is a regulatory milestone that transitions Egetis from development to…